Dayforce said Thoma Bravo is discussing buying the firm for $70 per share, with the company adding that there can be no assurances as to whether an agreement for a transaction will be reached.
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
A quiet Monday saw the Dow slip and the Nasdaq barely green as traders braced for Fed minutes and Jackson Hole. Fresh IRS guidance unexpectedly eased the blow for solar and wind, igniting ENPH, RUN, FSLR and SEDG. Deal talk sent Dayforce rocketing, while Intel lagged on chatter of a potential U.S. government stake.
Shares of HR software provider Paycom (NYSE:PAYC) jumped 3.3% in the afternoon session after the stock gained on M&A speculation within the human resources software sector, following a report that private equity firm Thoma Bravo is in talks to acquire competitor Dayforce.
Shares of human capital management software company Dayforce (NYSE:DAY) jumped 27.6% in the afternoon session after reports emerged that the company is in advanced talks to be acquired by private equity firm Thoma Bravo. The news, first reported by Bloomberg, suggests a deal to take the Minneapolis-based human resources software provider private could be announced within the next few weeks. While a sale price wasn't disclosed, some reports valued the potential transaction at over $9 billion. The rally sent Dayforce shares on track for their biggest-ever one-day gain since going public in April 2018, making the stock a top performer in the S&P 500 index.
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Dayforce shares skyrocketed 26% in Monday’s midday trade after reports suggested that private equity firm Thoma Bravo is in talks to acquire the human resources firm.
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
The financial markets are abuzz with significant movements across various sectors, driven by a confluence of strategic investments, groundbreaking regulatory approvals, and the enduring influence of retail investor sentiment. From Warren Buffett's latest healthcare bet to the Trump administration's potential foray into semiconductor manufacturing, and a major pharmaceutical breakthrough, these
